Mitochondrial calcium uptake in Alzheimer’s disease
阿尔茨海默病中的线粒体钙摄取
基本信息
- 批准号:10689146
- 负责人:
- 金额:$ 24.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-15 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:3xTg-AD mouseAbeta clearanceAblationAgeAgreementAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloidAmyloid beta-ProteinAmyloidosisAutophagocytosisBrainCalciumCalcium SignalingCause of DeathCell DeathCell LineCell RespirationCellular StressClinicalCoupledDataDefectDevelopmentDiseaseDisease ProgressionEconomic BurdenEventExhibitsGenerationsGenesGeneticGenetic ModelsImpaired cognitionImpairmentLinkMediatingMedical Care CostsMemoryMemory LossMetabolicMetabolic dysfunctionMitochondriaMitochondrial MatrixModelingMolecularMolecular WeightMusMutant Strains MiceNerve DegenerationNeurofibrillary TanglesNeuronal DysfunctionNeuronsOxidative StressPathogenesisPathogenicityPathologicPathologyPathway interactionsPhaseProteinsReactive Oxygen SpeciesReportingResearchRoleSamplingSenile PlaquesSignal PathwaySignal TransductionSynapsesTestingTimeToxic effectTrainingTransgenic Miceabeta depositionage relatedcalcium uniportercareercognitive skillextracellulargain of functionhyperphosphorylated taumisfolded proteinmitochondrial dysfunctionmutantneuron lossneuropathologynew therapeutic targetnovel therapeutic interventionoverexpressionparalogous geneprotein aggregationproteostasisrelease of sequestered calcium ion into cytoplasmscaffoldstoichiometrytau Proteinstheoriesuptake
项目摘要
Abstract:
Alzheimer's disease (AD) is characterized by the loss of memory accompanied by neuronal cell death and
metabolic dysfunction. Numerous studies have reported a dysregulation in neuronal intracellular calcium
(1Ca2+) signaling as an early event in AD pathogenesis. It is thought that a prolonged elevation in neuronal 1Ca2+
promotes excessive mitochondrial calcium (mCa2+) uptake, yet to date no study has examined the contribution
of mCa2+ uptake to disease progression. Since mCa2+ flux is an important regulator of cellular respiration and
cell death, both of which are involved in AD pathogenesis, we hypothesize that mCa2+ overload is a key
contributor to AD pathology and may contribute to metabolic deficits and neuronal demise. To define the role of
mCa2+ exchange in AD we have generated 3xTg-AD mutant mice with neuronal-specific deletion of
Mitochondrial Calcium Uniporter (MCU), which is required for mCa2+ uptake. In addition, we have generated a
gain-of-function mutant mouse expressing the recently identified mitochondrial calcium uniporter beta subunit
(MCUb). MCUb was recently reported as a negative regulator of mCa2+ uptake and we have observed
substantial changes in its expression in AD. These models will allow causative experimentation to test if mCa2+
uptake drives AD progression. Mice will be examined for alterations in memory, amyloidosis, tau-pathology,
oxidative stress, synaptic and metabolic function. Preliminary data suggest that mCa2+ uptake overload impairs
the clearance of misfolded proteins and dysfunctional mitochondria. Therefore, we will mechanistically examine
the link between mCa2+ exchange and autophagic and mitophagic pathways. Optimally, the proposed studies
will discover new therapeutic targets for AD and associated mitochondrial dysfunction and provide a training
and research platform to promote the Pis independent research career.
摘要:
阿尔茨海默病(AD)的特征是记忆丧失并伴有神经细胞死亡和
代谢功能障碍。许多研究已经报道了神经细胞内钙离子的失调。
(1)钙信号转导是AD发病机制中的早期事件。据认为,神经元1Ca~(2+)的持续升高
促进线粒体钙的过度摄取,但到目前为止还没有研究证实这一作用
线粒体钙摄取与疾病进展的关系。由于mCa~(2+)流量是细胞呼吸的重要调节因子
细胞死亡,这两个都参与了AD的发病,我们假设mCa2+超载是一个关键
导致AD病理改变,并可能导致代谢缺陷和神经元死亡。定义…的角色
我们已经产生了3xTg-AD突变小鼠,其神经元特异性缺失了
线粒体钙统一转运体(MCU),这是线粒体钙摄取所必需的。此外,我们还生成了一个
表达最近发现的线粒体钙单转运体β亚基的功能获得突变小鼠
(MCUb)。MCUb最近被报道为mCa~(2+)摄取的负调节因子,我们观察到
它在AD中的表达发生了实质性的变化。这些模型将允许因果实验来测试mCa2+
摄取推动AD的进展。将检查小鼠的记忆变化,淀粉样变性,tau病理,
氧化应激、突触和代谢功能。初步数据表明,mCa~(2+)摄取过载会损害
清除错误折叠的蛋白质和功能失调的线粒体。因此,我们将机械地审查
钙离子交换与自噬和有丝分裂途径之间的联系。最好的情况是,拟议的研究
将发现AD和相关线粒体功能障碍的新治疗靶点,并提供培训
和研究平台,推动PIS自主研究事业。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pooja Jadiya其他文献
Pooja Jadiya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pooja Jadiya', 18)}}的其他基金
Mitochondrial calcium uptake in Alzheimer's disease
阿尔茨海默病中的线粒体钙摄取
- 批准号:
10239248 - 财政年份:2020
- 资助金额:
$ 24.59万 - 项目类别:
Mitochondrial calcium uptake in Alzheimer's disease. Admin Supplement
阿尔茨海默病中的线粒体钙摄取。
- 批准号:
10782299 - 财政年份:2020
- 资助金额:
$ 24.59万 - 项目类别:
Mitochondrial calcium uptake in Alzheimer’s disease
阿尔茨海默病中的线粒体钙摄取
- 批准号:
10668706 - 财政年份:2020
- 资助金额:
$ 24.59万 - 项目类别:
Mitochondrial calcium uptake in Alzheimer's disease
阿尔茨海默病中的线粒体钙摄取
- 批准号:
10055513 - 财政年份:2020
- 资助金额:
$ 24.59万 - 项目类别:
相似海外基金
Environmental copper exposure and its impact on microglial Abeta clearance
环境铜暴露及其对小胶质细胞 Abeta 清除的影响
- 批准号:
8757425 - 财政年份:2014
- 资助金额:
$ 24.59万 - 项目类别:
Development of Novel Therapies for AD Targeting Abeta Clearance
针对 Abeta 清除的 AD 新型疗法的开发
- 批准号:
8820188 - 财政年份:2014
- 资助金额:
$ 24.59万 - 项目类别:
Development of Novel Therapies for AD Targeting Abeta Clearance
针对 Abeta 清除的 AD 新型疗法的开发
- 批准号:
9040023 - 财政年份:2014
- 资助金额:
$ 24.59万 - 项目类别:
Environmental copper exposure and its impact on microglial Abeta clearance
环境铜暴露及其对小胶质细胞 Abeta 清除的影响
- 批准号:
8930156 - 财政年份:2014
- 资助金额:
$ 24.59万 - 项目类别:
Caloric restriction and Alzheimers ABeta clearance pathway
热量限制和阿尔茨海默病 Aβ 清除途径
- 批准号:
8897941 - 财政年份:2013
- 资助金额:
$ 24.59万 - 项目类别:
Caloric restriction and Alzheimers ABeta clearance pathway
热量限制和阿尔茨海默病 Aβ 清除途径
- 批准号:
8411069 - 财政年份:2013
- 资助金额:
$ 24.59万 - 项目类别:
Caloric restriction and Alzheimers ABeta clearance pathway
热量限制和阿尔茨海默病 Aβ 清除途径
- 批准号:
8713897 - 财政年份:2013
- 资助金额:
$ 24.59万 - 项目类别:
The role of human ApoE in soluble ABeta clearance through the LDLR in vivo
人 ApoE 在体内通过 LDLR 清除可溶性 Aβ 中的作用
- 批准号:
7752282 - 财政年份:2009
- 资助金额:
$ 24.59万 - 项目类别:
The role of human ApoE in soluble ABeta clearance through the LDLR in vivo
人 ApoE 在体内通过 LDLR 清除可溶性 Aβ 中的作用
- 批准号:
8090296 - 财政年份:2009
- 资助金额:
$ 24.59万 - 项目类别:
Development of therapeutics for dementia targeting Abeta clearance
开发针对 Abeta 清除的痴呆疗法
- 批准号:
20590697 - 财政年份:2008
- 资助金额:
$ 24.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)